Showing results (181-190 of 6,863) with videos related to
Sort By:
Pageof 687
Headache|August 20, 2005
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatmentJeffrey S Brown, George Papadopoulos, Peter J Neumann, et al.The American Journal of Managed Care|April 12, 2008
A strategic plan for integrating cost-effectiveness analysis into the US healthcare systemPeter J Neumann, Jennifer A Palmer, Norman Daniels, et al.Health Affairs Scholar|July 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?Molly T Beinfeld, Fariel LaMountain, Glenn Phillips, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan DrugsKatherine A Clifford, A Alex Levine, Daniel E Enright, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Impact of referral patterns on the use of chemotherapy for lung cancerCraig C Earle, Peter J Neumann, Richard D Gelber, et al.Journal of General Internal Medicine|April 16, 2020
Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan DrugsJames D Chambers, Madison C Silver, Flora C Berklein, et al.Journal of Cancer Research and Therapeutics|April 11, 2025
Evaluation of three-dimensional setup errors using cone beam computed tomography (CBCT) for mediastinal lymphoma treated with volumetric modulated arc radiotherapy (VMAT) and deep inspiratory breath-hold (DIBH) techniqueSamarpita Mohanty, Sangram Pradhan, Divya Patil, et al.Health Economics|May 6, 2004
When does quality-adjusting life-years matter in cost-effectiveness analysis?Richard H Chapman, Marc Berger, Milton C Weinstein, et al.Medical Care|August 29, 2022
Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage PopulationYingying Zhu, Benjamin Koethe, Daniel A Ollendorf, et al.Pharmacoeconomics|September 24, 2021
Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 PandemicYumi Asukai, Andrew Briggs, Louis P Garrison, et al.Pageof 687